Your session is about to expire
← Back to Search
intervention arm for Suicide (SP6+ Trial)
SP6+ Trial Summary
This trial aims to test a safety intervention for Veterans who are at risk of suicide and seek emergency care. The intervention focuses on reducing access to lethal methods of self-harm, such as firearms and medications
SP6+ Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSP6+ Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.SP6+ Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is it possible for me to participate in this research study?
"In order to be eligible for participation in this clinical trial, patients must demonstrate suicidal tendencies and fall within the age range of 18 to 100 years old. Approximately 30 individuals will have the opportunity to participate in this study."
Is the registration process currently ongoing for this clinical trial?
"Indeed, the details on clinicaltrials.gov indicate that this ongoing clinical trial is actively searching for eligible candidates. The initial posting of the trial was recorded on January 8th, 2024 and it underwent its latest update on January 10th, 2024. Currently, there are openings for enrollment of up to 30 participants across a single location."
Is the clinical trial open to individuals who are below 18 years old?
"This study seeks to recruit individuals who are at least 18 years old and less than 100 years of age."
What is the current number of individuals receiving medical care as part of this research study?
"Indeed, the information provided on clinicaltrials.gov indicates that this ongoing clinical trial is currently seeking eligible participants. The initial posting date for this study was January 8th, 2024, and it was last updated on January 10th, 2024. The research team aims to recruit a total of 30 patients from one location."
Share this study with friends
Copy Link
Messenger